Innovative UK medicinal cannabis distributor Grow Pharma today announced that they have trialed the first UK extraction of a CBMP in a licensed facility, other than GW Pharmaceuticals, in their efforts to replicate and distribute cannabis-based medicinal products (CBMPs) to patients whose supply may be disrupted due to technicalities relating to Brexit. “Although it has been announced that a temporary solution has been found and companies are working on a longer-term solution which may take months, a post Brexit, sustainable and UK based solution for this problem is needed and we are ready to step up to help,” says Pierre van Weperen, CEO of Grow Pharma. He also mentioned that when prescriptions come in, initial samples will be made available free of charge and the actual cost moving forward will be significantly less than parents are used to paying. Grow Pharma are already legally importing GMP produced Bedrocan flowers into the UK for distribution to medicinal cannabis patients.

Mmp News Author, Medical Marijuana Program Connection, 02/01/2021 23:26:00

Open article: